万赛维去哪里买？

(Valganciclovir Hydrochloride Tablets) is developed by the pharmaceutical giant Roche and is generally used clinically to prevent CMV infection in high-risk solid organ transplant patients or to treat cytomegalovirus (CMV) in patients with acquired immunodeficiency syndrome (AIDS). The therapeutic effect of the drug is remarkable, and it can significantly delay the survival period of patients and improve their quality of life. Where should patients buy Valganciclovir Hydrochloride Tablets?

According to Medical Companion Travel, Vancevi (valganciclovir hydrochloride tablets) is currently on the market in China and can be purchased with a prescription in regular pharmacies and hospitals. However, because Vancevir (valganciclovir hydrochloride tablets) is an imported drug in China, the price is a bit more expensive. The domestic Vancevir (valganciclovir hydrochloride) specification is 450mg-60 tablets/box, and the price is about US$2,250.

Families who feel that the price of Chinese Vancevir (Valganciclovir Hydrochloride Tablets) is relatively high and unaffordable may consider purchasing Vancevir (Valganciclovir Hydrochloride Tablets) from India. India's Vancevir (valganciclovir hydrochloride tablets) is also an original drug developed by Roche Pharmaceuticals and approved for marketing in India. The price is only US$750 per box. The drug effects and applicable symptoms are exactly the same. It has been on the market for many years and has been well received by many CMV patients, so CMV patients can use it with confidence.

If you want to buy Indian Vancevir (Valganciclovir Hydrochloride Tablets) but are worried about buying counterfeit drugs, you can consult overseas medical institutions (such as Medical Companion Travel). Medical Companion Travel has cooperative relationships with foreign pharmaceutical companies and can help domestic patients purchase genuine and guaranteed Indian Vancevir (Valganciclovir Hydrochloride Tablets) without going abroad.

(valgansiklovir) adverse events (% of patients) were diarrhea (30%), tremor (28%), graft rejection (24%), nausea (23%), headache (22%), leg edema (21%), constipation (20%), back pain (20%), insomnia (20%), hypertension (18%), and vomiting (16%).